Mizuho Securities Maintains Align Technology(ALGN.US) With Buy Rating, Maintains Target Price $250
Align Technology (NASDAQ:ALGN) Will Want To Turn Around Its Return Trends
Align Technology Inc. Stock Rallies 3.7%, Outperforms Competitors
Align Technology Announces Commercial Availability of Invisalign With Mandibula
Express News | Align Technology Announces Invisalign® System With Mandibular Advancement Featuring Occlusal Blocks for Class II Skeletal and Dental Correction
CVS, COR, Among Top S&P 500 Healthcare Gainers in Q1; WST and MRNA Among Losers
Press Release: Align Technology to Announce First Quarter 2025 Results on April 30, 2025
Align Technology Announces Invisalign System With Mandibular Advancement Featuring Occlusal Blocks for Class II Skeletal and Dental Correction
Align Technology to Announce First Quarter 2025 Results on April 30, 2025
SprintRay Inc. Announces API Integration With Align Technology's ITero Intraoral Scanners to Further Ease Adoption Into Chairside Digital Dentistry
Mizuho Securities Maintains Align Technology(ALGN.US) With Buy Rating, Cuts Target Price to $250
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says
Mizuho Maintains Outperform on Align Technology, Lowers Price Target to $250
Mizuho Adjusts Price Target on Align Technology to $250 From $295, Maintains Outperform Rating
Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com
Align Technology, Inc. (NASDAQ:ALGN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Stifel Maintains Align Technology(ALGN.US) With Buy Rating
Positive Outlook for Align Technology Amidst Stabilizing Market Share and Competitive Pressures
Express News | FOMC Projects Lower GDP and Uncertainty, No Rate Change
Analysts See Upside For 95% Of S&P 500 Stocks: How Nvidia, Tesla Stack Up